Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells.
Carlo-Stella C
Adv Exp Med Biol. 610:100-11. doi: 10.1007/978-0-387-73898-7_8
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders.
Pierdominici M
FASEB J. 2013 Nov 6;28(2):524-35. doi: 10.1096/fj.13-235655
Autologous bone marrow transplantation in acute myelogenous leukemia.
Rizzoli V, Mangoni L, Carlo-Stella C
Leukemia. 6(11):1101-6.
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
Sarina B
Transpl Infect Dis. 2018 May 16;20(4):e12906. doi: 10.1111/tid.12906
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?
Carbone A, Gloghini A, Carlo-Stella C
Blood. 2018 May 1;132(1):17-22. doi: 10.1182/blood-2018-02-833806
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments.
Righi M
Lab Invest. 2009 Aug 3;89(9):1063-70. doi: 10.1038/labinvest.2009.76
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).
Chiesa C
Eur J Nucl Med Mol Imaging. 2009 May 20;36(11):1745-57. doi: 10.1007/s00259-009-1141-x
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.
Carlo-Stella C
Hum Gene Ther. 17(12):1225-40.
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone.
Carlo-Stella C
Exp Hematol. 32(2):171-8.
Amifostine (WR-2721) selective protection against melphalan genotoxicity.
Buschini A
Leukemia. 14(9):1642-51.